Assessment of the pulmonary CYP1A1 metabolism of mavoglurant (AFQ056) in rat.

Saved in:
Bibliographic Details
Title: Assessment of the pulmonary CYP1A1 metabolism of mavoglurant (AFQ056) in rat.
Authors: Yilmaz Y; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Umehara K; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Williams G; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Faller T; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Schiller H; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Walles M; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Kraehenbuehl S; b Clinical Pharmacology and Toxicology, University Hospital Basel , Switzerland , and., Camenisch G; a Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research , Basel , Switzerland., Manevski N; c Drug Metabolism and Pharmacokinetics , UCB, Slough , United Kingdom.
Source: Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2018 Aug; Vol. 48 (8), pp. 793-803. Date of Electronic Publication: 2017 Sep 29.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1366-5928 (Electronic) Linking ISSN: 00498254 NLM ISO Abbreviation: Xenobiotica Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1366-5928
DOI:10.1080/00498254.2017.1373311